
Cost of developing a drug in the U.S. from the 1970s until today (in million U.S. dollars)*
Loading statistic...
Basic Account
Get to know the platform
You only have access to basic statistics.
Starter Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$149 USD / Month *
Professional Account
Full access
Business Solutions including all features.
* Prices do not include sales tax.
Other statistics that may interest you U.S. pharmaceutical industry
Contribution to global pharma
5
- Premium Statistic World pharmaceutical market distribution by submarket 2014-2022
- Premium Statistic World pharmaceutical sales 2020-2022 by region
- Basic Statistic Market share of the leading global pharmaceutical markets 2022
- Premium Statistic Top global pharmaceutical markets: growth rate 2022
- Premium Statistic Top 50 pharmaceutical companies - Rx sales and R&D spending 2022
Overview
6
- Premium Statistic U.S. total medicine spending 2002-2022
- Basic Statistic Leading therapy areas for U.S. drug spending 2020
- Premium Statistic U.S. top prescribed drugs based on sales 2022
- Premium Statistic Top pharma products by prescriptions U.S. 2020
- Premium Statistic Pharmaceutical channel distribution by U.S. spending 2017-2019
- Premium Statistic U.S. biopharmaceutical export volume 2002-2022
Companies
6
- Premium Statistic 2022 list of top U.S. biotech and pharmaceutical companies based on revenue
- Premium Statistic Pharmaceutical corporations by U.S. revenue 2021
- Basic Statistic AbbVie's revenue 2010-2022
- Premium Statistic Pfizer's total revenue 2006-2022
- Premium Statistic Bristol-Myers Squibb's revenue 2006-2022
- Premium Statistic Johnson & Johnson's total sales 2005-2022
Research and development
7
- Basic Statistic Research and development expenditure: U.S. pharmaceutical industry 1995-2022
- Premium Statistic U.S. pharma industry R&D spending as a percent of total revenues 1990-2022
- Basic Statistic Pharmaceuticals: cost of drug development in the U.S. since 1975
- Premium Statistic Number of novel drugs approved annually by CDER 2008-2022
- Premium Statistic Number of orphan designations accepted in the U.S. 2003-2022
- Basic Statistic U.S. sales of new brand medicines 2012-2021
- Basic Statistic R&D expenditure per employee in U.S. sectors 2003-2017
Generics
5
- Basic Statistic Spending change on branded and generic medicines in the U.S. 2014-2021
- Premium Statistic U.S. brand and generic prescription drug spending 2017-2021
- Premium Statistic Branded vs. generic U.S. drug prescriptions dispensed 2005-2021
- Premium Statistic Savings through generic drug usage in the U.S. 2008-2022
- Premium Statistic Sales share at risk of pharmaceuticals due to patent expiries U.S. 2022
Public view on pharma
6
- Premium Statistic Share of U.S. people who had a favorable view of pharmaceutical companies 2021
- Premium Statistic U.S. approval of pharma companies' COVID-19 vaccine development handling 2021
- Premium Statistic Share of U.S. adults who approve pharmaceutical companies' drug price handling 2021
- Basic Statistic Share of people who had a favorable view of Pfizer in U.S. 2021
- Basic Statistic Share of people who had a favorable view of Moderna in U.S. 2021
- Premium Statistic Share of people who had a favorable view of J&J in U.S. 2021
Outlook
4
- Premium Statistic World pharmaceutical sales by region forecast 2026
- Premium Statistic Sales at risk of pharmaceuticals due to patent expiries U.S. 2022
- Basic Statistic Leading U.S. pharmaceutical products by revenue 2026
- Basic Statistic U.S. cannabinoid-based pharmaceuticals market size 2020-2029 projection
Further related statistics
17
- Americans' impression of the US pharma industry quality of drugs, by ethnicity 2017
- Sales growth changes of patented drugs in Canada 2021
- Value of expiring patents in U.S. 2016-2019
- Quantity change of patented drugs in Canada by therapy class 2015-2016
- Patented drug 2021 sales share distribution by date of first NOC
- U.S. top 10 prescribed drugs based on market share 2019
- Patent drug sales impact on change in expenditure by therapy class in Canada 2017
- Rate of price change for patented drugs by country 2021
- Pharmaceutical industry: global breakdown in the sale of new drugs 2004-2022
- Top specialty drug pharmacies in the U.S. by revenue 2022
- Genetic drugs: percentage of patents worldwide 2010
- Duration of drug development
- Genetic drugs: percentage of patents
- Italy: monthly value of medicaments imports 2017-2018
- Volume of China's drug market 2007-2015
- Industry revenue of “Pharmaceutical and medicine manufacturing“ in Canada 2012-2024
- Reasons for not shopping consumer healthcare products online in Poland 2020
Further Content: You might find this interesting as well
Statistics
- Americans' impression of the US pharma industry quality of drugs, by ethnicity 2017
- Sales growth changes of patented drugs in Canada 2021
- Value of expiring patents in U.S. 2016-2019
- Quantity change of patented drugs in Canada by therapy class 2015-2016
- Patented drug 2021 sales share distribution by date of first NOC
- U.S. top 10 prescribed drugs based on market share 2019
- Patent drug sales impact on change in expenditure by therapy class in Canada 2017
- Rate of price change for patented drugs by country 2021
- Pharmaceutical industry: global breakdown in the sale of new drugs 2004-2022
- Top specialty drug pharmacies in the U.S. by revenue 2022
- Genetic drugs: percentage of patents worldwide 2010
- Duration of drug development
- Genetic drugs: percentage of patents
- Italy: monthly value of medicaments imports 2017-2018
- Volume of China's drug market 2007-2015
- Industry revenue of “Pharmaceutical and medicine manufacturing“ in Canada 2012-2024
- Reasons for not shopping consumer healthcare products online in Poland 2020
PhRMA. (December 15, 2020). Cost of developing a drug in the U.S. from the 1970s until today (in million U.S. dollars)* [Graph]. In Statista. Retrieved December 10, 2023, from https://www.statista.com/statistics/265054/pharmaceuticals-cost-of-development-in-the-us/
PhRMA. "Cost of developing a drug in the U.S. from the 1970s until today (in million U.S. dollars)*." Chart. December 15, 2020. Statista. Accessed December 10, 2023. https://www.statista.com/statistics/265054/pharmaceuticals-cost-of-development-in-the-us/
PhRMA. (2020). Cost of developing a drug in the U.S. from the 1970s until today (in million U.S. dollars)*. Statista. Statista Inc.. Accessed: December 10, 2023. https://www.statista.com/statistics/265054/pharmaceuticals-cost-of-development-in-the-us/
PhRMA. "Cost of Developing a Drug in The U.S. from The 1970s until Today (in Million U.S. Dollars)*." Statista, Statista Inc., 15 Dec 2020, https://www.statista.com/statistics/265054/pharmaceuticals-cost-of-development-in-the-us/
PhRMA, Cost of developing a drug in the U.S. from the 1970s until today (in million U.S. dollars)* Statista, https://www.statista.com/statistics/265054/pharmaceuticals-cost-of-development-in-the-us/ (last visited December 10, 2023)
Cost of developing a drug in the U.S. from the 1970s until today (in million U.S. dollars)* [Graph], PhRMA, December 15, 2020. [Online]. Available: https://www.statista.com/statistics/265054/pharmaceuticals-cost-of-development-in-the-us/